Dr. Englund’s research interests include the study of the diagnosis, prevention, and treatment of viral respiratory diseases in children, pregnant women, and immunocompromised hosts. She studies respiratory viruses including  RSV and SARS-CoV-2 in healthy and immunocompromised children, as well as respiratory vaccines and novel methods of antiviral therapy for respiratory viruses including influenza and respiratory syncytial virus (RSV). Dr. Englund has been a coinvestigator in maternal immunization studies with influenza and RSV vaccines, and currently is studying maternal-fetal antibody transmission following immunization or infection with Dr. Alisa Kachikis in the Dept. of Obstetrics/Gynecology at the University of Washington.  As a Clinical Associate at Fred Hutchinson Cancer Research Center, she is involved in transplant-related protocols with Drs. Michael Boeckh and Alpana Waghmare studying the prevention, treatment, and outcome of respiratory viral diseases in transplant recipients of all ages. 

Dr. Englund’s research group at Seattle Children’s Hospital is part of the New Vaccine Surveillance Network of the Centers for Disease Control (CDC), participating in respiratory and gastrointestinal viral surveillance in collaboration with Dr. Eileen Klein, Pediatric Emergency Department, since 2010. Dr. Englund and her team are actively involved in studies of new respiratory vaccines as well as vaccine effectiveness, including studies of COVID-19 vaccines and RSV passive immunization effectiveness in infants. She also is studying dosing of COVID-19 booster vaccines in young children and household surveillance studies as part of the CASCADIA and RIGHT studies sponsored by the Centers for Disease controls.  Our research group is also studying methods to diagnose and characterize viral respiratory diseases utilizing SARS-CoV-2 serological studies of individuals and populations over time.  Dr. Englund is a frequent speaker at local, national, and international meetings. She is a past member of the WHO Influenza working group, the CDC Advisory Group on Immunization Practices, and the FDA Vaccine Advisory Committee,  and a current member of the Influenza Working Group and SARS-CoV-2 Diagnosis Working Group of the Infectious Disease Society of America.